*Some Market data delayed by 15 mins.

Cellectis S.A. American Depositary Shares

Symbol: CLLS (NASDAQ)
2.09 ▲ (4.70%) 0.094

Company Description:
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.

Key Stats
  • Today's Open: $2.03
  • Today's High: $2.18
  • Today's Low: $2
  • Today's Volume: 41.21K
  • Yesterday Close: $2
  • Yesterday High: $2.01
  • Yesterday Low: $1.88
  • Yesterday Volume: 59.07K
  • Last Min Volume: 10
  • Last Min High: $2.094
  • Last Min Low: $2.078
  • Last Min VWAP: $2.078
Company Profile
  • Name: Cellectis S.A. American Depositary Shares
  • Website: https://www.cellectis.com
  • Listed Date: 2015-03-25
  • Location: ,
  • Market Status: Active
  • CIK Number: 0001627281
  • SIC Code:
  • SIC description:
  • Market Cap: $209.20M
  • Round Lot: 100
  • Outstanding Shares: 100.09M
  • Asset Type: ADRC
RECENT FILINGS FOR CLLS
Filing DateFiling TypeFormat
2024-06-286-KView
2024-06-286-KView
2024-06-206-KView
2024-06-126-KView
2024-06-046-KView
2024-05-296-KView
2024-05-286-KView
2024-05-286-KView
2024-05-286-KView
2024-05-246-KView
2024-05-21SC 13D/AView
2024-05-066-KView
2024-05-036-KView
2024-04-2920-FView
2024-04-226-KView
2024-04-106-KView
2024-04-086-KView
2024-02-14SC 13G/AView
2024-02-14SC 13G/AView
2024-01-166-KView
Latest News

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.